Evidence map›Paper›PMID 38180553›Full record

ArticleApplied microbiology and biotechnology2024

Quercetin: a promising virulence inhibitor of Pseudomonas aeruginosa LasB in vitro.

Yanying Ren, Rui Zhu, Xiaojuan You, Dengzhou Li, Mengyu Guo, Bing Fei, Ying Liu, Ximing Yang, Xinwei Liu, Yongwei Li

Open access · goldAbstract read
In one paragraph

Article in Applied microbiology and biotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
8.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Antibacterial and anti-virulence effects ofMicrobiology spectrum · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Genetic mutations enhance the production of Exotoxin A byExperimental and therapeutic medicine · 2025
    Article
  18. Article
  19. Article
  20. Phytochemical Composition and Biological Properties ofAntioxidants (Basel, Switzerland) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Yanying RenHenan University of Chinese Medicine, Zhengzhou, 450046, China.
Rui ZhuHenan University of Chinese Medicine, Zhengzhou, 450046, China.
Xiaojuan YouHenan University of Chinese Medicine, Zhengzhou, 450046, China.
Dengzhou LiHenan University of Chinese Medicine, Zhengzhou, 450046, China.
Mengyu GuoHenan University of Chinese Medicine, Zhengzhou, 450046, China.
Bing FeiHenan University of Chinese Medicine, Zhengzhou, 450046, China.
Ying LiuHenan University of Chinese Medicine, Zhengzhou, 450046, China.
Ximing YangDongzhimen Hospital of Beijing University of Chinese Medicine, Peking, 100700, China. yximing2005@163.com.
Xinwei LiuHenan University of Chinese Medicine, Zhengzhou, 450046, China. 43154727@qq.com.ORCID http://orcid.org/0000-0002-5358-886X
Yongwei LiHenan University of Chinese Medicine, Zhengzhou, 450046, China. lyw@hactcm.edu.cn.
Henan University of Traditional Chinese Medicine · CNFirst Affiliated Hospital of Henan University · CNDongzhimen Hospital Affiliated to Beijing University of Chinese Medicine · CN

Funding

Foundation of Henan Educational Committee 22A360008Health Commission of Henan Province 2022ZY1078Health Commission of Henan Province 2023XY1011
6 · The paper itself

Abstract

With the inappropriate use of antibiotics, antibiotic resistance has emerged as a major dilemma for patients infected with Pseudomonas aeruginosa. Elastase B (LasB), a crucial extracellular virulence factor secreted by P. aeruginosa, has been identified as a key target for antivirulence therapy. Quercetin, a natural flavonoid, exhibits promising potential as an antivirulence agent. We aim to evaluate the impact of quercetin on P. aeruginosa LasB and elucidate the underlying mechanism. Molecular docking and molecular dynamics simulation revealed a rather favorable intermolecular interaction between quercetin and LasB. At the sub-MICs of ≤256 μg/ml, quercetin was found to effectively inhibit the production and activity of LasB elastase, as well as downregulate the transcription level of the lasB gene in both PAO1 and clinical strains of P. aeruginosa. Through correlation analysis, significant positive correlations were shown between the virulence gene lasB and the QS system regulatory genes lasI, lasR, rhlI, and rhlR in clinical strains of P. aeruginosa. Then, we found the lasB gene expression and LasB activity were significantly deficient in PAO1 ΔlasI and ΔlasIΔrhlI mutants. In addition, quercetin significantly downregulated the expression levels of regulated genes lasI, lasR, rhlI, rhlR, pqsA, and pqsR as well as effectively attenuated the synthesis of signaling molecules 3-oxo-C12-HSL and C4-HSL in the QS system of PAO1. Quercetin was also able to compete with the natural ligands OdDHL, BHL, and PQS for binding to the receptor proteins LasR, RhlR, and PqsR, respectively, resulting in the formation of more stabilized complexes. Taken together, quercetin exhibits enormous potential in combating LasB production and activity by disrupting the QS system of P. aeruginosa in vitro, thereby offering an alternative approach for the antivirulence therapy of P. aeruginosa infections. KEY POINTS: • Quercetin diminished the content and activity of LasB elastase of P. aeruginosa. • Quercetin inhibited the QS system activity of P. aeruginosa. • Quercetin acted on LasB based on the QS system.

Indexed as

Pseudomonas aeruginosaQuercetinHumansMolecular Docking SimulationPancreatic ElastaseVirulencePancreatic ElastaseQuercetinAntivirulence therapyLasB elastasePseudomonas aeruginosaQuercetinQuorum sensing

Identifiers

PMID38180553
PMCPMC10770215
OpenAlexW4390610034

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.